Barbara Hickingbottom

Dr. Barbara Hickingbottom joined AskGene Pharma in May 2022 bringing over 20 years of experience in biologics clinical development. From 2016 until she joined AskGene, she worked in clinical development at Xencor in positions of increasing responsibility. In her last position as Head of Clinical Development at Xencor, she was responsible for all of the company’s clinical stage products. Prior to Xencor, Dr. Hickingbottom worked as both a consultant and an employee in many biopharmaceutical companies, including BioMarin, Mannkind, Novartis, Xoma, Novacea, and CTL Immunotherapies.

Dr. Hickingbottom received her M.D. from the Tufts University School of Medicine and completed her internship and residency in pathology at Stanford. She also received a J. D. from the Harvard Law School and, prior to medical school, practiced law in Boston.